|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 96, 730-740, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
A Takahashi, DJ Chambers, MV Braimbridge and DJ Hearse
There is often a large difference between volumes of crystalloid
cardioplegic solution used clinically (2 to 4 ml/gm myocardium) and
experimentally (in rat heart preparations, volumes of 30 ml/gm or more are
used). In an attempt to reconcile these differences and define the minimum
volume and/or duration of infusion of the St. Thomas' Hospital cardioplegic
solution consistent with maximal myocardial protection, we have used the
isolated working rat heart to characterize the relationships between
myocardial protection and (1) the duration of cardioplegic infusion and (2)
the volume of cardioplegic infusion. Hearts (n = 6 per group, weighing 0.90
+/- 0.06 gm) were subjected to 0, 5, 10, 15, 30, 45, 60, 120, 180, 240, or
300 seconds of cardioplegic infusion (mean infusion volumes = 0, 1.3 +/-
0.1, 2.0 +/- 0.1, 2.8 +/- 0.2, 5.0 +/- 0.1, 8.3 +/- 0.2, 10.5 +/- 0.8, 21.8
+/- 2.1, 22.7 +/- 1.3, 32.3 +/- 2.1, and 39.1 +/- 1.8 ml per heart,
respectively) before 30 minutes of normothermic ischemia. They recovered
3.9% +/- 2.3%, 9.7% +/- 5.0%, 22.8% +/- 5.8%, 34.6% +/- 4.6%, 54.7% +/-
6.6%, 64.0% +/- 5.0%, 67.4% +/- 4.0%, 56.6% +/- 11.1%, 60.0% +/- 5.8%,
51.6% +/- 7.0%, and 68.0% +/- 7.8% of their preischemic cardiac output on
reperfusion. Creatine kinase leakage, tissue adenosine triphosphate and
creatine phosphate content, and other indices of cardiac function supported
this observation. To assess volume of infusion rather than duration, we
infused hearts (n = 6 per group) with 1.0, 1.5, or 2.0 ml of cardioplegic
solution over 120 seconds. Although recovery of cardiac output with 2.0 ml
(56.2% +/- 6.8%) was not significantly different from that (56.6% +/-
11.1%) observed with large volumes of solution (21.9 +/- 2.1 ml), infusion
of 1.5 and 1.0 ml resulted in poor recovery of cardiac output (40.1% +/-
4.6% and 21.8% +/- 3.9%, respectively). To assess duration (with low
volumes) rather than volume of infusion, we infused hearts (n = 6 per
group) with 2.0 ml of cardioplegic solution over 10, 30, 60, or 120
seconds. Maximal protection was observed with 30, 60, and 120 seconds of
infusion (recovery of cardiac output = 56.7% +/- 5.9%, 45.1% +/- 7.9%, and
56.2% +/- 6.8%, respectively). Our results suggest that, for maximum
myocardial protection, the St. Thomas' Hospital solution should be infused
at a rate of not less than 2.0 ml/gm wet weight of heart and that the
duration of infusion should be not less than 30 seconds.
ARTICLES
Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion
Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, England.
This article has been cited by other articles:
![]() |
J. A. Dearani, T. C. Axford, M. A. Patel, N. A. Healey, P. T. Lavin, and S. F. Khuri Role of myocardial temperature measurement in monitoring the adequacy of myocardial protection during cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2235 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Snabaitis, M. J. Shattock, and D. J. Chambers Comparison of Polarized and Depolarized Arrest in the Isolated Rat Heart for Long-term Preservation Circulation, November 4, 1997; 96(9): 3148 - 3156. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |